{"id":33256,"title":"Supplements ‘Ozempic Face’ to counter side effects of rapid weight-loss","publisher":"Stockmark.IT","author":"Stockmark.IT Website","published":"2024-06-25T05:07:13+00:00","modified":"2024-06-25T05:07:13+00:00","canonical_url":"https://stockmark.it/supplements-ozempic-face-to-counter-side-effects-of-rapid-weight-loss/","markdown_url":"https://stockmark.it/supplements-ozempic-face-to-counter-side-effects-of-rapid-weight-loss.md","json_url":"https://stockmark.it/supplements-ozempic-face-to-counter-side-effects-of-rapid-weight-loss.json","category":"Business","categories":["Business","Drug Research"],"featured_image":"https://i0.wp.com/stockmark.it/wp-content/uploads/stencil.default-2024-06-25T060640.494.jpg?fit=1200%2C800&quality=89&ssl=1","format":"news","language":"en-GB","content":"Nestle will sell dietary supplements that counter the effects of weight loss drugs to “Ozempic Face”.\n\nThe company announced that it would launch products to “complement” weight loss treatments. These include hair growth supplements and electrolyte tablet that improves skin elasticity.\n\nKitKat and Smarties maker is bracing for a drop in sales for ice cream and sweets due to the booming demand for products like Ozempic.\n\nAnna Mohl is the CEO of Nestle Health Science Division. She told Bloomberg that it will keep up with changes in customer needs, such as “preserving lean muscles mass, managing digestion upset, and ensuring an adequate daily intake of micronutrients”.\n\nThe supplements should help combat the “Ozempic Face” . This is a side effect of taking semaglutide, a diabetes drug for weight loss. It causes the skin to lose its elasticity and the face to look gaunt.\n\nThe side effect is named after Novo Nordisk’s Ozempic treatment. This is a diabetes medication that is off-label used to treat obesity. Novo Nordisk makes Wegovy, a weight-loss medication that has proven to help patients lose 15pc on average.\n\nIn April, the Swiss skincare company Galderma said that it expected a surge in demand for fillers. This is because more people are starting to use obesity treatments and do not wish to lose weight on their faces.\n\nNestle’s move comes at a time when food manufacturers are preparing to counter the pressure on sales that more weight loss treatments will bring.\n\nMark Schneider, Nestle’s chief executive said last month that the company expected a drop in sales due to the drugs. The drugs work by suppressing the appetite.\n\nHe said: “In my case, it will be frozen foods, confectionery and to some degree ice cream.”\n\nNestle, the company that makes Haagen Dazs, has launched a new line of pastas and pies enriched with protein for those who are taking anti-obesity drugs.\n\nLast month, it was said that these products provided “the right nutrition” – high proteins, good fiber, and the right minerals.\n\nRecent studies suggest that patients who receive the treatment consume up to 30pc less calories.\n\nInjections for obesity have seen a surge in sales over the last year. One in four US adults has taken GLP-1.\n\nNovo Nordisk is racing to meet the high demand for these drugs. Wegovy is expected to be available on the NHS in the UK for up to 50,000 patients.\n\nNovo Nordisk announced on Monday that it would spend $4.1bn to expand production of obesity drugs within the US. The company called this “one of the biggest manufacturing investments in Novo Nordisk history”."}